JACC-CARDIOONCOL 潤(rùn)色咨詢

JACC: CardioOncology

出版年份:2019 年文章數(shù):121 投稿命中率: 開(kāi)通期刊會(huì)員,數(shù)據(jù)隨心看

出版周期:季刊 自引率:暫無(wú)數(shù)據(jù) 審稿周期: 開(kāi)通期刊會(huì)員,數(shù)據(jù)隨心看

前往期刊查詢

投稿信息

投稿信息
審稿費(fèi)用
1000.0元/篇 (網(wǎng)友貢獻(xiàn),非官方數(shù)據(jù))
版面費(fèi)用
500.0元/篇 (網(wǎng)友貢獻(xiàn),非官方數(shù)據(jù))
中國(guó)人發(fā)表比例
2023年中國(guó)人文章占該期刊總數(shù)量2.50% (2022年為0.00%)
自引率
暫無(wú)數(shù)據(jù)
年文章數(shù)
121
期刊官網(wǎng)
點(diǎn)擊查看 (點(diǎn)擊次數(shù):1291)
投稿鏈接
點(diǎn)擊查看 (點(diǎn)擊次數(shù):829次)
作者需知
點(diǎn)擊查看 (點(diǎn)擊次數(shù):735次)
期刊簡(jiǎn)介
稿件收錄要求

JACC: CardioOncology is one of a family of specialist journals launched by the renowned Journal of the American College of Cardiology (JACC). It serves to advance the cardiovascular care of cancer patients through the publication of rigorously executed, innovative science and dissemination of evidence-based knowledge. The journal seeks to transform the field of cardio-oncology and actively engage and educate the cardiovascular and oncology communities in pre-clinical, translational, and clinical research, as well as in best practices in cardio-oncology. Broad areas of interest include original research studies in disease mechanisms, in vitro and in vivo model systems, novel and conventional therapeutics (Phase I-IV), epidemiology, precision medicine, and primary and secondary prevention. Disease states of interest include, but are not limited to amyloidosis, cardiovascular risk factors, heart failure, and vascular disease.